Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

NCT01373736 is registered in ClinicalTrials.gov with Vancouver Coastal Health as lead sponsor.

NCT NCT01373736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Lead sponsor
Vancouver Coastal Health
Phase
Phase 3
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid tumors, medullary thyroid carcinoma, neuroblastoma, paraganglioma, pheochromocytoma